Löppönen T, Pääkkö E, Laitinen J, Saukkonen A L, Serlo W, Tapanainen P, Ruokonen A, Pirttiniemi P, Poikela A, Knip M
Department of Paediatrics, University of Oulu, Finland.
Clin Endocrinol (Oxf). 1997 Jun;46(6):691-9. doi: 10.1046/j.1365-2265.1997.1931004.x.
Most previous reports of endocrine disorders in children with shunted hydrocephalus have been case reports and there is a lack of systematic information on pituitary anatomy and function among these children. We have obtained these data in a large group of individuals with shunted hydrocephalus.
A controlled cross-sectional study.
Fifty-four children and adolescents with shunted hydrocephalus were studied for pituitary anatomy and function. They had 54 age- and sex-matched controls (group I). The mean age of the patients and controls was 12.6 years and the mean shunting period 10.6 years. There was a second control group (II) for the magnetic resonance imaging (MRI) and a third control group (III) for the radiography of the sella turcica.
The anatomy was visualized by MRI of the pituitary gland and by radiography of the sella turcica. The functional evaluation included an arginine-insulin test and a combined stimulation test with corticotrophin releasing factor (CRF), GnRH and TRH.
The patients were shorter (height 148.4 cm vs 153.7 cm, P < 0.05 and relative height -0.5 SDS vs 0.4 SDS, P < 0.05) and had a higher BMI than the control group I (20.6 kg/m2 vs 18.0 kg/m2, P < 0.001). They had also a greater pituitary height than the control group II (5.8 mm vs 5.1 mm, P < 0.01). The patients had significantly lower basal GH levels (P < 0.001) than controls I. Sixteen patients (30%) had a poor GH response (< 20 mU/l) in the arginine-insulin test. Pituitary height was significantly lower among these patients than in those with a normal response (4.7 mm vs 6.3 mm, P < 0.01), who had an increased pituitary height compared to controls II (5.1 mm, P < 0.01). The area under the curve (AUC) for GH correlated with the pituitary volume (r = 0.50, P < 0.001). The patients had higher basal FSH and LH concentrations than controls I (P < 0.001). The peak to basal ratios of FSH and LH were increased in the prepubertal patients and that of LH at Tanner pubertal stage II in the females. The basal FSH and LH levels correlated with the pituitary volume (r = 0.50 and r = 0.54, P < 0.001 for), as did FSH AUC and LH AUC (r = 0.48 and r = 0.75, P < 0.001 for both).
These observations indicate that children with shunted hydrocephalus have an increased pituitary size on average. About one-third of these patients had signs of reduced GH secretion and significantly lower pituitary height, which probably contributes to their poor linear growth. Increased pituitary size was associated with enhanced gonadotrophin secretion, which may result in early puberty in children with shunted hydrocephalus.
既往大多数关于分流性脑积水患儿内分泌紊乱的报道均为病例报告,缺乏有关这些患儿垂体解剖结构和功能的系统性信息。我们在一大群分流性脑积水患者中获取了这些数据。
一项对照横断面研究。
对54例患有分流性脑积水的儿童和青少年进行垂体解剖结构和功能研究。他们有54名年龄和性别匹配的对照者(第一组)。患者和对照者的平均年龄为12.6岁,平均分流时间为10.6年。有用于磁共振成像(MRI)的第二对照组(第二组)和用于蝶鞍X线摄影的第三对照组(第三组)。
通过垂体MRI和蝶鞍X线摄影观察解剖结构。功能评估包括精氨酸 - 胰岛素试验以及促肾上腺皮质激素释放因子(CRF)、促性腺激素释放激素(GnRH)和促甲状腺激素释放激素(TRH)联合刺激试验。
患者身高较矮(身高148.4 cm对153.7 cm,P < 0.05;相对身高 -0.5 SDS对0.4 SDS,P < 0.05),且体重指数高于第一对照组(20.6 kg/m²对18.0 kg/m²,P < 0.001)。他们的垂体高度也高于第二对照组(5.8 mm对5.1 mm,P < 0.01)。患者的基础生长激素(GH)水平显著低于第一对照组(P < 0.001)。16例患者(30%)在精氨酸 - 胰岛素试验中生长激素反应不佳(< 20 mU/l)。这些患者的垂体高度显著低于反应正常者(4.7 mm对6.3 mm,P < 0.01),而反应正常者的垂体高度高于第二对照组(5.1 mm,P < 0.01)。生长激素曲线下面积(AUC)与垂体体积相关(r = 0.50,P < 0.001)。患者的基础促卵泡生成素(FSH)和促黄体生成素(LH)浓度高于第一对照组(P < 0.001)。青春期前患者FSH和LH的峰谷比升高,女性在坦纳青春期II期LH的峰谷比升高。基础FSH和LH水平与垂体体积相关(r = 0.50和r = 0.54,两者P < 0.001),FSH AUC和LH AUC也相关(r = 0.48和r = 0.75,两者P < 0.001)。
这些观察结果表明,分流性脑积水患儿的垂体平均大小增加。约三分之一的这些患者有生长激素分泌减少的迹象且垂体高度显著降低,这可能是其线性生长不良的原因。垂体大小增加与促性腺激素分泌增强有关,这可能导致分流性脑积水患儿青春期提前。